Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Potassium in Acute Ankle Sprain
NCT01666197Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Ankle sprain comparing Diclofenac Potassium with Placebo (2 arms). Primary endpoint: Pain on Movement at 48 hours. Started Aug 2012; status: completed.
02
Drugs
diclofenac
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on NCT01666197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666197.